Home / Posts Tagged "biosimilars"

OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE), multi-modality specialty pharma pure-play CDMO, and Xbrane Biopharma AB (Nasdaq ticker XBRANE), a Sweden-headquartered biotechnology company, today announced a strategic partnership focused on the commercial manufacturing of Xbrane’s biosimilar portfolio.   Xbrane has a portfolio of biosimilar candidates targeting

READ MORE

On Wednesday, the U.S. House Judiciary Committee voted to approve three bills to restrain practices drugmakers use to raise prices and fend off competition, including a bill to ban the tactic of paying generic companies to delay bringing cheaper versions of their medicines to market.Committee

READ MORE